Updated:
Nueterra Capital
Nueterra Capital was founded in 1995 by Dan Nueterra, who built the firm on proceeds from healthcare and real estate ventures.
Nueterra Capital
Nueterra Capital was founded in 1995 by Dan Nueterra, who built the firm on proceeds from healthcare and real estate ventures. The Nueterra family's wealth originated from building and selling multiple healthcare service businesses, including a chain of surgical hospitals and related real estate assets. The firm operates as a multi-family office, managing capital for the founding family and a small group of like-minded families. The firm's strategy spans direct investments, co-investments, and fund commitments across healthcare services, real estate, and private credit. In healthcare, Nueterra has backed companies such as USPI (United Surgical Partners International) and several ASC (ambulatory surgery center) operators. Real estate activity includes development and ownership of medical office buildings and other healthcare-related properties. The private credit arm provides direct lending to middle-market healthcare and real estate companies. Geographically, the firm focuses on North America, with select opportunities in Europe. The team is estimated at roughly 58 professionals across eight offices in the United States, Switzerland, and Canada. In early 2024, Nueterra Capital closed a new healthcare credit fund, raising approximately $500 million from family offices and institutional investors (per industry reports, 2024). The firm also operates a philanthropic foundation, the Nueterra Foundation, which is separately managed. Nueterra's structural differentiator is its operating-company network: the firm's principals and advisors include former healthcare executives and operators who source proprietary deal flow from their own industry relationships. This gives Nueterra an informational advantage in healthcare and real estate transactions where it can co-invest alongside management teams. Succession planning is in place, with the next generation of the Nueterra family involved in investment committees.
General information
Firm type
Multi Family Office
Year founded
1995
AUM
Undisclosed (Altss estimate: $1B - $5B)
Location
Region
North America
Country
United States
City
Leawood
Corporate office
Leawood, KS, United States
Additional offices
Menlo Park, CA · Natick, MA · San Francisco, CA · Geneva, Switzerland · Salt Lake City, UT · Chicago, IL · Toronto, Canada
Principals
Dan Nueterra
Founder & Managing Partner
Bob Nueterra
Co-Founder & Partner
Mike Mills
Managing Director
Sector focus
Frequently asked questions
Who runs investment decisions at Nueterra Capital?
Dan Nueterra, founder and managing partner, leads investment strategy alongside co-founder Bob Nueterra and managing director Mike Mills. The firm operates through an investment committee that includes family members and external advisors. Decision-making authority is concentrated among the senior partners, with sector-specific teams in healthcare and real estate.
How does Nueterra Capital source proprietary deal flow?
Nueterra's deal flow is sourced through its operating-company network — former and current healthcare executives, real estate developers, and industry advisors who provide access to off-market opportunities. The firm does not rely on investment banks or auctions. This network is a direct extension of the founders' entrepreneurial experience in healthcare.
Is Nueterra Capital structured as a single family office or a multi-family office?
Nueterra is structured as a multi-family office, managing capital for the founding Nueterra family and a select group of like-minded families and institutions. The firm's website describes itself as a 'multi-family office' and its investment activities include co-investments with external partners. The firm maintains separate structures for philanthropic activities.
Does Nueterra Capital participate in fund commitments or only direct deals?
Nueterra does both: it makes direct investments in companies and real estate, and also commits capital to external private equity and credit funds. The firm's private credit arm focuses on direct lending to middle-market companies, particularly in healthcare. Its fund commitments are typically to managers with sector expertise in healthcare and real estate.
What investment stages does Nueterra Capital typically target?
Nueterra targets a range from growth equity to buyout and credit, with a focus on established middle-market companies. In healthcare, the firm invests in both platform companies and add-on acquisitions for existing portfolio businesses. Real estate investments are typically in development or stabilized assets. The credit strategy targets direct lending opportunities.
Which sectors does Nueterra Capital explicitly avoid?
Nueterra has a stated focus on healthcare services and real estate, and has not publicly disclosed any sectors it explicitly avoids. However, based on its portfolio history, the firm has limited exposure to technology, energy, or consumer businesses. Its sector concentration suggests a deliberate avoidance of sectors outside its core expertise.
Where does the underlying wealth at Nueterra Capital come from?
The underlying wealth originates from the Nueterra family's entrepreneurial ventures in healthcare services and real estate. The family built and sold multiple surgical hospital chains, ambulatory surgery centers, and related real estate assets over several decades. This capital was then redeployed into the multi-family office structure.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on family offices?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: